Search Results - "Metodieva, Anna"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    The functional interplay between the t(9;22)-associated fusion proteins BCR/ABL and ABL/BCR in Philadelphia chromosome-positive acute lymphatic leukemia by Rafiei, Anahita, Mian, Afsar Ali, Döring, Claudia, Metodieva, Anna, Oancea, Claudia, Thalheimer, Frederic B, Hansmann, Martin Leo, Ottmann, Oliver Gerhard, Ruthardt, Martin

    Published in PLoS genetics (01-04-2015)
    “…The hallmark of Philadelphia chromosome positive (Ph(+)) leukemia is the BCR/ABL kinase, which is successfully targeted by selective ATP competitors. However,…”
    Get full text
    Journal Article
  2. 2

    Overcoming Bcr-Abl T315I mutation by combination of GNF-2 and ATP competitors in an Abl-independent mechanism by Khateb, Mamduh, Ruimi, Nili, Khamisie, Hazem, Najajreh, Yousef, Mian, Afsar, Metodieva, Anna, Ruthardt, Martin, Mahajna, Jamal

    Published in BMC cancer (27-11-2012)
    “…Philadelphia positive leukemias are characterized by the presence of Bcr-Abl fusion protein which exhibits an abnormal kinase activity. Selective Abl kinase…”
    Get full text
    Journal Article
  3. 3

    Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I by Mian, Afsar Ali, Metodieva, Anna, Badura, Susanne, Khateb, Mamduh, Ruimi, Nili, Najajreh, Yousef, Ottmann, Oliver Gerhard, Mahajna, Jamal, Ruthardt, Martin

    Published in BMC cancer (17-09-2012)
    “…Chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive (Ph+) acute lymphatic leukemia (Ph + ALL) are caused by the t(9;22), which fuses BCR to…”
    Get full text
    Journal Article
  4. 4

    p185BCR/ABL has a lower sensitivity than p210BCR/ABL to the allosteric inhibitor GNF-2 in Philadelphia chromosome-positive acute lymphatic leukemia by MIAN, Afsar A, METODIEVA, Anna, NAJAJREH, Yousef, OTTMANN, Oliver G, MAHAJNA, Jamal, RUTHARDT, Martin

    Published in Haematologica (Roma) (01-02-2012)
    “…Background The t(9;22) translocation leads to the formation of the chimeric breakpoint cluster region/c-abl oncogene 1 (BCR/ABL) fusion gene on der22, the…”
    Get full text
    Journal Article
  5. 5

    The functional interplay between the t by Rafiei, Anahita, Mian, Afsar Ali, Doring, Claudia, Metodieva, Anna, Oancea, Claudia, Thalheimer, Frederic B, Hansmann, Martin Leo, Ottmann, Oliver Gerhard, Ruthardt, Martin

    Published in PLoS genetics (01-04-2015)
    “…The hallmark of Philadelphia chromosome positive ([Ph.sup.+]) leukemia is the BCR/ABL kinase, which is successfully targeted by selective ATP competitors…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Prominin-1/CD133 Is Involved in the Lineage Decision As Well As a in the Sensitivity to Molecular Therapy in Ph+ Acute Lymphatic Leukemia by Metodieva, Anna T., Pfeifer, Heike, Mian, Afsar, Vogel, Anja, Serve, Hubert, Ottmann, Oliver G., Ruthardt, Martin

    Published in Blood (16-11-2012)
    “…Abstract 2579 Chronic myelogenous leukemia (CML) and Philadephia chromosome-positive acute lymphatic leukemia (Ph+ ALL) is caused by the t(9;22) which fuses…”
    Get full text
    Journal Article
  8. 8
  9. 9

    The Reciprocal t(9;22) p96ABL/BCR fusion Protein Eenhances the Transformation Potential of BCR/ABL and Increases Therapy Resistance in Models of Ph+ Acute Lymphatic Leukemia by Rafiei, Anahita, Mian, Afsar, Metodieva, Anna, Oancea, Claudia, Serve, Hubert, Pfeifer, Heike, Ottmann, Oliver G., Ruthardt, Martin

    Published in Blood (16-11-2012)
    “…Abstract 3539 The t(9;22)(q34;q11) is a balanced translocation. The cytogenetic correlate of der22 is the so-called Philadelphia chromosome (Ph). Der22…”
    Get full text
    Journal Article
  10. 10

    PF-114, a Novel Selective Pan BCR/ABL Inhibitor Targets The T315I and Suppress Models Of Advanced Ph+ ALL by Mian, Afsar, Rafiei, Anahita, Metodieva, Anna, Haberbosch, Isabella, Zeifman, Alexey, Titov, Ilya, Stroylov, Victor, Stroganov, Oleg, Novikov, Fedor, Ottmann, Oliver G., Chilov, Ghermes, Ruthardt, Martin

    Published in Blood (15-11-2013)
    “…Targeting BCR/ABL by ABL-directed kinase inhibitors (AKIs) induces long lasting remissions in patients with chronic myeloid leukemia (CML), and short…”
    Get full text
    Journal Article
  11. 11

    p185(BCR/ABL) has a lower sensitivity than p210(BCR/ABL) to the allosteric inhibitor GNF-2 in Philadelphia chromosome-positive acute lymphatic leukemia by Mian, Afsar A, Metodieva, Anna, Najajreh, Yousef, Ottmann, Oliver G, Mahajna, Jamal, Ruthardt, Martin

    Published in Haematologica (Roma) (01-02-2012)
    “…The t(9;22) translocation leads to the formation of the chimeric breakpoint cluster region/c-abl oncogene 1 (BCR/ABL) fusion gene on der22, the Philadelphia…”
    Get full text
    Journal Article
  12. 12

    The Degree of Response of Philadelphia Chromosome Positive Acute Lymphatic Leukemia to Allosteric Inhibition by GNF-2 Depends on the Presence of Either p185-BCR/ABL or p210-BCR/ABL by Mian, Afsar, Metodieva, Anna, Najajreh, Yousef, Serve, Hubert, Ottmann, Oliver, Mahajna, Jamal, Ruthardt, Martin

    Published in Blood (19-11-2010)
    “…Abstract 598 The t(9;22) translocation (Ph+) leads to the formation of the chimeric bcr/abl fusion gene, which encodes the BCR/ABL fusion protein. Depending on…”
    Get full text
    Journal Article